Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age

Standard

Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age. / Tilki, Derya; Maurer, Valentin; Pompe, Raisa S; Chun, Felix K; Preisser, Felix; Haese, Alexander; Graefen, Markus; Huland, Hartwig; Mandel, Philipp.

In: WORLD J UROL, Vol. 38, No. 1, 01.2020, p. 95-101.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Tilki, D, Maurer, V, Pompe, RS, Chun, FK, Preisser, F, Haese, A, Graefen, M, Huland, H & Mandel, P 2020, 'Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age', WORLD J UROL, vol. 38, no. 1, pp. 95-101. https://doi.org/10.1007/s00345-019-02740-8

APA

Tilki, D., Maurer, V., Pompe, R. S., Chun, F. K., Preisser, F., Haese, A., Graefen, M., Huland, H., & Mandel, P. (2020). Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age. WORLD J UROL, 38(1), 95-101. https://doi.org/10.1007/s00345-019-02740-8

Vancouver

Bibtex

@article{05987155e8bc430298954af1707a1620,
title = "Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age",
abstract = "PURPOSE: Age is an important prognostic factor for functional and oncological outcomes after radical prostatectomy (RP). Considering the long life-expectancy of young patients (≤ 45 years), it remains important to examine their outcomes.METHODS: Of 16.049 patients who underwent RP between 01/2006 and 12/2014 at the Martini-Klinik Prostate Cancer Center, 119 (0.7%) were ≤ 45. Known prognosticators were compared according to patient age at RP (categorical as ≤ 45, > 45 and ≤ 65, > 65 years). Kaplan-Meier plots and Cox-regressions analyzed oncological outcomes [biochemical recurrence (BCR)-free survival and metastasis-free survival (MFS)]. Logistic regressions were used for functional outcome. Urinary continence (UC) was defined as the use of 0 or 1 safety pad/day and potency as an IIEF-5 score of ≥ 18.RESULTS: Compared to their older counterparts, patients ≤ 45 years had more favorable tumor characteristics. Of all patients aged ≤ 45 years, 89% underwent bilateral and 9.3% unilateral nerve-sparing procedure. Five year BCR-free survival and MFS were 80.2% and 98.7% for patients ≤ 45 years, 72.8% and 95.0% for patients > 45 and ≤ 65 years and 70.5% and 94.9% for patients > 65 years. For the same groups, 1-year UC-rates were 97.4%, 89.4%, and 84.7% while 1.3%, 8.2%, and 11.6% used 1-2 pads/24 h. At 1-year, 75.6%, 58.6%, and 45.3% of preoperatively potent patients who underwent bilateral nerve-sparing were considered potent. Younger age was an independent predictor of favorable functional outcome also in multivariable analysis.CONCLUSIONS: Patients aged ≤ 45 years had more favorable tumor characteristics and oncological outcomes. Moreover, younger patients should be counseled about the excellent postoperative continence and potency rates.",
author = "Derya Tilki and Valentin Maurer and Pompe, {Raisa S} and Chun, {Felix K} and Felix Preisser and Alexander Haese and Markus Graefen and Hartwig Huland and Philipp Mandel",
year = "2020",
month = jan,
doi = "10.1007/s00345-019-02740-8",
language = "English",
volume = "38",
pages = "95--101",
journal = "WORLD J UROL",
issn = "0724-4983",
publisher = "Springer",
number = "1",

}

RIS

TY - JOUR

T1 - Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age

AU - Tilki, Derya

AU - Maurer, Valentin

AU - Pompe, Raisa S

AU - Chun, Felix K

AU - Preisser, Felix

AU - Haese, Alexander

AU - Graefen, Markus

AU - Huland, Hartwig

AU - Mandel, Philipp

PY - 2020/1

Y1 - 2020/1

N2 - PURPOSE: Age is an important prognostic factor for functional and oncological outcomes after radical prostatectomy (RP). Considering the long life-expectancy of young patients (≤ 45 years), it remains important to examine their outcomes.METHODS: Of 16.049 patients who underwent RP between 01/2006 and 12/2014 at the Martini-Klinik Prostate Cancer Center, 119 (0.7%) were ≤ 45. Known prognosticators were compared according to patient age at RP (categorical as ≤ 45, > 45 and ≤ 65, > 65 years). Kaplan-Meier plots and Cox-regressions analyzed oncological outcomes [biochemical recurrence (BCR)-free survival and metastasis-free survival (MFS)]. Logistic regressions were used for functional outcome. Urinary continence (UC) was defined as the use of 0 or 1 safety pad/day and potency as an IIEF-5 score of ≥ 18.RESULTS: Compared to their older counterparts, patients ≤ 45 years had more favorable tumor characteristics. Of all patients aged ≤ 45 years, 89% underwent bilateral and 9.3% unilateral nerve-sparing procedure. Five year BCR-free survival and MFS were 80.2% and 98.7% for patients ≤ 45 years, 72.8% and 95.0% for patients > 45 and ≤ 65 years and 70.5% and 94.9% for patients > 65 years. For the same groups, 1-year UC-rates were 97.4%, 89.4%, and 84.7% while 1.3%, 8.2%, and 11.6% used 1-2 pads/24 h. At 1-year, 75.6%, 58.6%, and 45.3% of preoperatively potent patients who underwent bilateral nerve-sparing were considered potent. Younger age was an independent predictor of favorable functional outcome also in multivariable analysis.CONCLUSIONS: Patients aged ≤ 45 years had more favorable tumor characteristics and oncological outcomes. Moreover, younger patients should be counseled about the excellent postoperative continence and potency rates.

AB - PURPOSE: Age is an important prognostic factor for functional and oncological outcomes after radical prostatectomy (RP). Considering the long life-expectancy of young patients (≤ 45 years), it remains important to examine their outcomes.METHODS: Of 16.049 patients who underwent RP between 01/2006 and 12/2014 at the Martini-Klinik Prostate Cancer Center, 119 (0.7%) were ≤ 45. Known prognosticators were compared according to patient age at RP (categorical as ≤ 45, > 45 and ≤ 65, > 65 years). Kaplan-Meier plots and Cox-regressions analyzed oncological outcomes [biochemical recurrence (BCR)-free survival and metastasis-free survival (MFS)]. Logistic regressions were used for functional outcome. Urinary continence (UC) was defined as the use of 0 or 1 safety pad/day and potency as an IIEF-5 score of ≥ 18.RESULTS: Compared to their older counterparts, patients ≤ 45 years had more favorable tumor characteristics. Of all patients aged ≤ 45 years, 89% underwent bilateral and 9.3% unilateral nerve-sparing procedure. Five year BCR-free survival and MFS were 80.2% and 98.7% for patients ≤ 45 years, 72.8% and 95.0% for patients > 45 and ≤ 65 years and 70.5% and 94.9% for patients > 65 years. For the same groups, 1-year UC-rates were 97.4%, 89.4%, and 84.7% while 1.3%, 8.2%, and 11.6% used 1-2 pads/24 h. At 1-year, 75.6%, 58.6%, and 45.3% of preoperatively potent patients who underwent bilateral nerve-sparing were considered potent. Younger age was an independent predictor of favorable functional outcome also in multivariable analysis.CONCLUSIONS: Patients aged ≤ 45 years had more favorable tumor characteristics and oncological outcomes. Moreover, younger patients should be counseled about the excellent postoperative continence and potency rates.

U2 - 10.1007/s00345-019-02740-8

DO - 10.1007/s00345-019-02740-8

M3 - SCORING: Journal article

C2 - 30937571

VL - 38

SP - 95

EP - 101

JO - WORLD J UROL

JF - WORLD J UROL

SN - 0724-4983

IS - 1

ER -